Christopher Treat, DO
Hand Surgery · Tulsa, OKNPI 1558771618
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,105 of the $21,923 with a category attached, or 68.9%. 22 manufacturers reported payments, led by Zimmer Biomet at 44.7% of the total. 2025 is the largest year on record at $11,687, 9.7 times the $1,205 reported in 2019.
Across 105 payments — averaging $208.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$10K
- Trice Medical, Inc.$9K
- Arthrex$1K
- Smith+Nephew$505
- Stryker$449
- Davol Inc.$228
- plus $611 from 16 others
What the payments were for
- Consulting fees$15,10569%
- Travel & lodging$2,0659%
- Food & beverage$3,55316%
- Education$1,2005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 26 | $9,800 |
| Trice Medical, Inc. | 16 | $9,017 |
| Arthrex | 2 | $1,313 |
| Smith+Nephew | 17 | $505 |
| Stryker | 17 | $449 |
| Davol Inc. | 5 | $228 |
| Johnson & Johnson | 2 | $147 |
| Baxter Healthcare | 3 | $111 |
| Vertex | 3 | $60 |
| Anika Therapeutics, Inc. | 1 | $51 |
| Pylant Medical | 1 | $32 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Dynasplint Systems Inc. | 1 | $28 |
| BD | 1 | $25 |
| Bioventus LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Kls-martin L.p. | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Alafair Biosciences, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,923 in reported general payments places this provider in the 85th percentile of 26 hand surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 739 | $8,159 |
| Cephalexin | 403 | $3,539 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 200 | $2,115 |
| Clindamycin Hcl | 67 | $482 |
| Gabapentin | 26 | $206 |
| Cyclobenzaprine Hcl | 30 | $137 |
| Tramadol Hcl | 25 | $101 |
| Oxycodone Hcl | 14 | $86 |
| Amoxicillin | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Tulsa
- William SheltonTulsa$23K
- Jessica ChildeTulsa$5K
- Jean-Louis GabrielTulsa$4K
- Robert VogelTulsa$1K
- Garrett WattsTulsa$133
- James BischoffTulsa$133
- William HarrisonTulsa$40
- Warren PoagTulsa$35
- Kristopher AvantYukon$35K
- Clayton NelsonOklahoma City$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.